HPV-associated diseases: questions and answers


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Human papillomavirus (HPV) is the most common sexually transmitted infection. Two thirds of women become infected within 2 years after the onset of sexual activity. HPV genetic material can be found in almost all forms of cervical cancer and in some cancers of the anogenital region and oropharynx. The problem of HPV-associated diseases and cervical cancer is very serious, due to the fact that the prevalence of HPV is extremely high. The total number of people infected with HPV is approaching 700 million. According to the available statistical data, favourable outcome of HPV-associated diseases can be observed mainly in young women, however, the diseases may run for quite a long period of time. Taking into account the characteristics of HPV-associated diseases, it is possible to use immunomodulatory drugs, such as inosine pranobex (Groprinosin). It can contribute to the activation of local immunity, as well as the creation of more favorable conditions for surgical treatment and prevention of relapses.

Full Text

Restricted Access

About the authors

Marina N. Kostava

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Ph.D., doctor of the scientific and polyclinic department, secretary of the international public organization "Association for Cervical Pathology and Colposcopy”.

References

  1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr. Eval. Carcinog. Risks Hum. 2012; 100(PtB): 1-441.
  2. Каприн А.Д., Старинский В.В., Шахзадова А.О., ред. Состояние онкологической помощи населению России в 2019 году. М.; 2020.
  3. Bruni L., Albero G., Serrano B., Mena M., Collado J.J. et al. IARC/ICO Information Centre on HPV and Cancer (HPV Information Centre). Human papillomavirus and related diseases in Russian Federation. Summary Report 22 October 2021. [Электронный ресурс] Available at: http://www.hpvcentre.net/statistics/reports/RUS.pdf?t=1548009998402
  4. Грецова О.П., Костин А.А., Самсонов Ю.В., Петрова Г.В., Простое М.Ю., Простое Ю.И. Заболеваемость и смертность от злокачественных новообразований, ассоциированных с вирусом папилломы человека. Исследования и практика в медицине. 2017; 4(3): 33-50. https://dx.doi.org/10.17709/2409-2231-2017-4-3-4.
  5. Workowski K.A., Bachmann L.H., Chan P.A., Johnston C.M., Muzny C.A., Park I. et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm. Rep. 2021; 70(4): 1-187. https://dx.doi.org/10.15585/mmwr.rr7004a1.
  6. WHO. Global health sector strategy on sexually transmitted infections 20162021 towards ending STIS (document WHA69/2016/REC/1).
  7. Rowley J., Vander Hoorn S., Korenromp E., Low N., Unemo M., Abu-Raddad L.J. et al. Global and regional estimates of the prevalence and incidence of four curable sexually transmitted infections in 2016. WHO Bulletin. June 2019.
  8. Прилепская В.Н., Сухих Г.Т., ред. Диагностика, лечение и профилактика цервикальных интраэпителиальных неоплазий. М.: МЕДпресс-информ; 2020. 80с.
  9. Довлетханова Э.Р., Прилепская В.Н. Дифференцированная тактика ведения пациенток с ВПЧ-ассоциированными заболеваниями гениталий. Акушерство и гинекология. 2015; 10: 118-24.
  10. Гусаков К.И., Назарова Н.М., Прилепская В.Н., Стародубцева Н.Л., Франкевич В.Е. Перспективы профилактики рака, ассоциированного с вирусом папилломы человека. Акушерство и гинекология. 2019; 8: 33-9. https://dx.doi.org/10.18565/aig.2019.8.33-39.
  11. Ribeiro A.L., Caodaglio A.S., Sichero L. Regulation of HPV transcription. Clinics (Sao Paulo). 2018; 73(Suppl. 1): e486s. https://dx.doi.org/10.6061/clinics/2018/e486s.
  12. Egawa N., Doorbar J. The low-risk papillomaviruses. Virus Res. 2017; 231: 119 27. https://dx.doi.org/10.1016/j.virusres.2016.12.017
  13. Koliopoulos G., Nyaga V.N., Santesso N., Bryant A., Martin-Hirsch P.P., Mustafa R.A. et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst. Rev. 2017; 8(8): CD008587. https://dx.doi.org/10.1002/14651858.CD008587.pub2.
  14. Bhatla N., Singhal S. Primary HPV screening for cervical cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 2020; 65: 98-108. https://dx.doi.org/10.1016/j.bpobgyn.2020.02.008.
  15. Medeiros R., Vaz S., Rebelo T., Figueiredo-Dias M. Prevention of human papillomavirus infection. Beyond cervical cancer: a brief review. Acta Med. Port. 2020; 33(3): 198-201. https://dx.doi.org/10.20344/amp.12259.
  16. Генитальная ВПЧ-инфекция - информационный бюллетень центра по контролю и профилактике заболеваний, CDC, USA [электронный ресурс]. [Global health sector strategy on sexually transmitted infections 2016-2021 towards ending STIS (document WHA69/2016/REC/1)]. Available at: https://www.cdc.gov/std/russian/stdfact-hpv-russian.htm
  17. Jain M.A., Limaiem F. Cervical intraepithelial squamous cell lesion. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
  18. Brianti P., De Flammineis E., Mercuri S.R. Review of HPV-related diseases and cancers. New Microbiol. 2017; 40(2): 80-5.
  19. Ngo-Metzger Q., Adsul P. Screening for cervical cancer. Am. Fam. Physician. 2019; 99(4): 253-4.
  20. Nayar R., Wilbur D.C. The Bethesda system for reporting cervical cytology: a historical perspective. Acta Cytol. 2017; 61(4-5): 359-72. https://dx.doi.org/10.1159/000477556.
  21. Министерство здравоохранения Российской Федерации. Письмо Министерства здравоохранения РФ от 2 ноября 2017 г. N. 15-4/10/ 2-7676. О направлении клинических рекомендаций (протокола лечения) «Доброкачественные и предраковые заболевания шейки матки с позиции профилактики рака».
  22. Sawaya G.F., Smith-McCune K., Kuppermann M. Cervical cancer screening: More choices in 2019. JAMA. 2019; 321(20): 2018-9. https://dx.doi.org/10.1001/jama.2019.4595.
  23. Гусаков К.И., Назарова Н.М., Франкевич В.Е., Стародубцева Н.Л., Бурменская О.В., Прилепская В.Н., Сухих Г.Т. Результаты генотипирования вируса папилломы человека у женщин репродуктивного возраста, вакцинированных от вируса папилломы человека. Акушерство и гинекология. 2020; 9: 114-9. https://dx.doi.org/10.18565/aig.2020.9.114-119.
  24. Chrysostomou A.C., Stylianou D.C., Constantinidou A., Kostrikis L.G. Cervical cancer screening programs in Europe: The transition towards HPV vaccination and population-based HPV testing. Viruses. 2018; 10(12): 729. https://dx.doi.org/10.3390/v10120729.
  25. Darragh T.M., Colgan T.J., Cox J.T., Heller D.S., Henry M.R., Luff R.D. et al.; Members of LAST Project Work Groups. The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch. Pathol. Lab. Med. 2012; 136(10): 1266-97. https://dx.doi.org/10.5858/arpa.LGT200570. Erratum in: Arch. Pathol. Lab. Med. 2013; 137(6):738.
  26. Tatti S., Bornstein J., Prendiville W. Colposcopy: a global perspective: introduction of the new IFCPC colposcopy terminology. Obstet. Gynecol. Clin. North Am. 2013; 40(2): 235-50. https://dx.doi.org/10.1016/j.ogc.2013.02.002.
  27. Жирарди Ф., Райх О., Тамуссино К., Пикель Х. Кольпоскопия и патология шейки матки по Бургхардту; Пер. с англ. Прилепская В.Н., ред. М.: МЕДпресс-информ; 2018. 224с.
  28. Khan M.J., Werner C.L., Darragh T.M., Guido R.S., Mathews C., Moscicki A.B. et al. ASCCP colposcopy standards: role of colposcopy, benefits, potential harms, and terminology for colposcopic practice. J. Low. Genit. Tract. Dis. 2017; 21(4): 223-9. 10. https://dx.doi.org/1097/LGT.0000000000000338.
  29. Bornstein J., Bentley J., Bosze P., Girardi F., Haefner H., Menton M. et al. 2011 Colposcopic terminology of the international federation for cervical pathology and colposcopy. Obstet. Gynecol. 2012; 120(1): 166-72. https://dx.doi.org/10.1097/AOG.0b013e318254f90c.
  30. IFCPC 2017 World Congress for Cervical Pathology and Colposcopy. April 4-7, 2017, Orlando, Florida; 2017.
  31. Korostil I., Ali H., Guy R., Donovan B., Law M.G., Regan D.G. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males. Sex. Transm. Dis. 2013; 40(11): 833-5. https://dx.doi.org/10.1097/0LQ.0000000000000030.
  32. Kovachev S.M. A review on inosine pranobex immunotherapy for cervical HPV-positive patients. Infect. Drug Resist. 2021; 14: 2039-49. https://dx.doi.org/10.2147/IDR.S296709.
  33. Sliva J., Pantzartzi C.N., Votava M. Inosine pranobex: a key player in the game against a wide range of viral infections and non-infectious diseases. Adv. Ther. 2019; 36(8): 1878-905. https://dx.doi.org/10.1007/s12325-019-00995-6.
  34. DAlessandro P., Arduino B., Borgo M., Saccone G., Venturella R., Di Cello A., Zullo F. Loop electrosurgical excision procedure versus cryotherapy in the treatment of cervical intraepithelial neoplasia: a systematic review and metaanalysis of randomized controlled trials. Gynecol. Minim. Invasive Ther. 2018; 7(4): 145-51. https://dx.doi.org/10.4103/GMIT.GMIT_56_18.
  35. Дикке Г.Б. Современные подходы к вторичной профилактике рака шейки матки. Акушерство и гинекология. 2018; 4: 131-7. [Dikke G.B. Modern approach in secondary preventive measures in treatment of cervical cancer. Obstetrics and Gynecology. 2018; 4: 131-7. (in Russian). https://dx.doi.org/10.18565/aig.2018.4.131-137.
  36. Прилепская В.Н., Новикова Е.П., Суламанидзе Л.А., Мзарелуа Г.М. Папилломавирусная инфекция. Возможности лечения и профилактики с применением инозин пранобекса. Акушерство и гинекология. 2013; 10: 99-103.
  37. Абакарова П.Р., Прилепская В.Н. ВПЧ-ассоциированные заболевания шейки матки. Возможности комплексной терапии. Гинекология. 2017; 19(5): 4-9. [Abakarova P.R., Prilepskaya V.N. HPV-associated diseases of the cervix. Complex therapy options. Gynecology. 2017; 19(5): 4-9. (in Russian)]. https://dx.doi.org/10.26442/2079-5696_19.5.4-9.
  38. Бурменская О.В., Назарова Н.М., Сычева Е.Г., Прилепская В.Н., Трофимов Д.Ю., Сухих Г.Т. Применение молекулярно-генетических методов для диагностики и прогноза развития дисплазии тяжелой степени и рака шейки матки. Акушерство и гинекология. 2021; 10: 85-92. https://dx.doi.org/10.18565/aig.2021.10.
  39. Гаспарян С.А., Овчинникова О.С. Оптимизация противовирусной терапии инозин пранобексом начальных поражений ВПЧ-ассоциированных заболеваний шейки матки. Акушерство и гинекология. 2015; 9: 94-7.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies